[1] ETHAYATHULLA A S,YOUSEF M S,AMIN A,et al. Structure-based mechanism for Na(+)/melibiose symport by MelB[J]. Nat Commun,2014,5:3009.
[2] ESNAULT C,PRIET S,RIBET D,et al. A placenta-specific receptor for the fusogenic,endogenous retrovirus-derived,human syncytin-2[J]. Proc Natl Acad Sci USA,2008,105(45):17532-17537.
[3] NGUYEN L N,MA D,SHUI G,et al. Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid[J]. Nature,2014,509(7501):503-506.
[4] ENGELHARDT B,LIEBNER S. Novel insights into the development and maintenance of the blood-brain barrier[J]. Cell Tissue Res,2014,355(3):687.
[5] WINKLER E A,NISHIDA Y,SAGARE A P,et al. GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration[J]. Nat Neurosci,2015,18(4):521.
[6] BEN-ZVI A,LACOSTE B,KUR E,et al. Mfsd2a is critical for the formation and function of the blood-brain barrier[J]. Nature,2014,509(7501):507-511.
[7] BETSHOLTZ C. Lipid transport and human brain development[J]. Nat Genet,2015,47(7):699-701.
[8] KEANEY J,CAMPBELL M. The dynamic blood-brain barrier[J]. FEBS J,2015,282(21):4067-4079.
[9] KADEREIT B,KUMAR P,WANG W J,et al. Evolutionarily conserved gene family important for fat storage[J]. Proc Natl Acad Sci USA,2008,105(1):94-99.
[10] BERGER J H,CHARRON M J,SILVER D L. Major facilitator superfamily domain-containing protein 2a (MFSD2A) has roles in body growth,motor function,and lipid metabolism[J]. PLoS One,2012,7(11):e50629.
[11] DANEMAN R,ZHOU L,KEBEDE A A,et al. Pericytes are required for blood-brain barrier integrity during embryogenesis[J]. Nature,2010,468(7323):562-566.
[12] ARMULIK A,GENOVÉ G,MÄE M,et al. Pericytes regulate the blood-brain barrier[J]. Nature,2010,468(7323):557-561.
[13] KEEP R F,HUA Y,XI G. Intracerebral haemorrhage:mechanisms of injury and therapeutic targets[J]. Lancet Neurol,2012,11(8):720-731.
[14] YANG Y R,XIONG X Y,LIU J,et al. Mfsd2a (major facilitator superfamily domain containing 2a) attenuates intracerebral hemorrhage-induced blood-brain barrier disruption by inhibiting vesicular transcytosis[J]. J Am Heart Assoc,2017,6(7):e005811.
[15] SALEM N J R,LITMAN B,KIM H Y,et al. Mechanisms of action of docosahexaenoic acid in the nervous system[J]. Lipids,2001,36(9):945.
[16] PARODER-BELENITSKY M,MAESTAS M J,DOHÁN O,et al. Mechanism of anion selectivity and stoichiometry of the Na+/I- symporter (NIS)[J]. Proc Natl Acad Sci U S A,2011,108(44):17933-17938.
[17] GUEMEZ-GAMBOA A,NGUYEN L N,YANG H,et al. Inactivating mutations in MFSD2A,required for omega-3 fatty acid transport in brain,cause a lethal microcephaly syndrome[J]. Nat Genet,2015,47(7):809-813.
[18] ALAKBARZADE V,HAMEED A,QUEK D Q,et al. A partially inactivating mutation in the sodium-dependent lysophosphatidylcholine transporter MFSD2A causes a non-lethal microcephaly syndrome[J]. Nat Genet,2015,47(7):814-817.
[19] HANAHAN D,WEINBERG R A.The hallmarks of cancer[J]. Cell,2000,100(1):57-70.
[20] SPINOLA M,FALVELLA F S,GALVAN A,et al. Ethnic differences in frequencies of gene polymorphisms in the MYCL1 region and modulation of lung cancer patients' survival[J]. Lung Cancer,2007,55(3):271-277.
[21] SPINOLA M,GALVAN A,PIGNATIELLO C,et al. Identification and functional characterization of the candidate tumor suppressor gene TRIT1 in human lung cancer[J]. Oncogene,2005,24(35):5502-5509.
[22] SPINOLA M,FALVELLA F S,COLOMBO F,et al. MFSD2A is a novel lung tumor suppressor gene modulating cell cycle and matrix attachment[J]. Mol Cancer,2010,9:62.
[23] PU W,ZHANG H,HUANG X,et al. Mfsd2a+ hepatocytes repopulate the liver during injury and regeneration[J]. Nat Commun,2016,7:13369.
[24] MIYAJIMA A,TANAKA M,ITOH T. Stem/progenitor cells in liver development,homeostasis,regeneration,and reprogramming[J]. Cell Stem Cell,2014,14(5):561-574.
[25] STANGER B Z. Probing hepatocyte heterogeneity[J]. Cell Res,2015,25(11):1181-1182.
[26] JUNGERMANN K,KATZ N. Functional specialization of different hepatocyte populations[J]. Physiol Rev,1989,69(3):708-764.
[27] MADDIPATI K R,ZHOU S L. Stability and analysis of eicosanoids and docosanoids in tissue culture media[J]. Prostaglandins Other Lipid Mediat,2011,94(1/2):59-72.
[28] MADDIPATI K R,ROMERO R. Clinical chorioamnionitis at term:the amniotic fluid fatty acyl lipidome[J]. J Lipid Res,2016,57(10):1906-1916.
[29] UNGARO F,TACCONI C,MASSIMINO L,et al. MFSD2A Promotes Endothelial Generation of Inflammation-resolving Lipid Mediators and Reduces Colitis in Mice[J]. Gastroenterology,2017,153(5):1363-1377. |
